StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PHAT

Phathom Pharmaceuticals, Inc.

PHAT Nasdaq Pharmaceutical Preparations EDGAR ↗
$8.98
-0.05 -0.55%

Key statistics

from XBRL data in SEC filings
Market cap
$726M
Revenue (TTM)
$240M
Net income (TTM)
$122M
EPS (TTM)
$-1.25
P/E ratio
Dividend yield
Free cash flow
-$167M
Cash
$182M
Total assets
$327M
Gross margin
82.9%
52-week range
$8.03 – $18.31

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Other events Jun 23, 2026 8-K Shareholder vote results May 21, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Other events Jan 8, 2026 8-K Results of operations (earnings release) Jan 7, 2026 8-K Other events Nov 4, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Other events Oct 27, 2025 8-K Director or officer change Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jun 16, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Regulation FD disclosure; Other events Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Director or officer change Apr 16, 2025 8-K Director or officer change Apr 1, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jul 18, 2024 10-K/A Fiscal year ended 2023-12-31 Jun 14, 2024 10-Q/A Quarter ended 2024-03-31 Jun 14, 2024 8-K Shareholder vote results; Other events May 24, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release) Mar 7, 2024